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Abstract In neurons, synaptic vesicle exocytosis involves the
formation of a core complex particle including syntaxin-1,
synaptosomal-associated protein of 25 kDa (SNAP-25) and
vesicle-associated membrane protein (VAMP)-2/synaptobrevin.
The expression of these proteins was investigated in a panel of
cell lines, including lines of endocrine and intestinal origin, by
Western blotting and/or immunocytochemistry. The three core
complex proteins were detected in the enteroendocrine, chole-
cystokinin (CCK)-secreting, cell lines STC-1 and GLUTag, and
in the endocrine non-intestinal cell lines CA-77 and HIT-T15. In
contrast, SNAP-25 and syntaxin-1 were undetected in the
intestinal non-endocrine cell lines IEC-6, HT-29 and Caco-2,
whereas a slight expression of VAMP-2 was documented in IEC-
6 and HT-29 cells. Co-immunoprecipitation experiments indi-
cated that syntaxin-1, SNAP-25 and VAMP-2 were present in a
complex similar to that identified in brain. In the STC-1 cell line,
treatment of streptolysin-O-permeabilized cells with tetanus
toxin (Tetx) selectively cleaved VAMP-2 and VAMP-3/cellu-
brevin, and simultaneously abolished Ca2+-induced CCK secre-
tion (IC50V12 nM). These results show that endocrine cell lines
of intestinal origin express syntaxin-1, SNAP-25 and VAMP-2,
and suggest a key role for a Tetx-sensitive protein (for example
VAMP-2 and/or VAMP-3) in the CCK secretion by STC-1 cells.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
In neuronal and hormonal cells, release of the signaling
substance depends on the precise targeting of transport
vesicles to speci¢c membrane compartments within the regu-
lated exocytotic pathway. The SNARE hypothesis [1] pro-
poses that this speci¢city is achieved through the mutual rec-
ognition of vesicle membrane (v-) and target membrane (t-)
SNAREs [soluble NSF attachment protein receptors (where
NSF = N-ethylmaleimide-sensitive fusion protein)] that assem-
ble into stable docking and fusion complexes. According to
this hypothesis, recent reports identi¢ed mammalian SNAREs
that are implicated in endoplasmic reticulum to Golgi [2,3],
and intra-Golgi transport [4]. In neurons, syntaxin-1 [5,6],
SNAP-25 [7] (synaptosomal-associated protein of 25 kDa)
and synaptobrevin II [8] [also known as vesicle-associated
membrane protein 2 (VAMP-2)] are the three SNARE pro-
teins that form the core complex involved in synaptic vesicle
fusion with plasma membrane [9^11]. Recently, these core
complex proteins were reported to be expressed in endocrine
cells from the adrenal medulla [12,13], anterior pituitary [13^
15] and pancreas [13,16^20]. Independent evidence for the
crucial role of these SNAREs in neurotransmitter and hor-
mone exocytosis came from studies using clostridial neurotox-
ins, tetanus toxin (Tetx) and botulinum toxins A to G [17^24],
that selectively cleave syntaxin-1, SNAP-25 or VAMP-2
[22,23,25]. Insulin release, for instance, was shown to be im-
paired by Tetx [17,19,20] and botulinum toxin serotypes A
[18,24], B [17], E [18] and F [24] in permeabilized insulinoma
cells.
The gut epithelium includes a variety of endocrine cells
derived, as endocrine pancreas, from the primary endoderm.
The fusion machinery involved in peptide secretion from the
di¡use endocrine system of the gut has not been identi¢ed.
The aim of this work was therefore to determine in the enter-
oendocrine cell lines STC-1 and GLUTag the presence of
syntaxin-1, SNAP-25 and VAMP-2, compared with endocrine
and non-endocrine cells of di¡erent origin. We here report
that STC-1 and GLUTag cells express both syntaxin-1,
SNAP-25 and VAMP-2, and that these proteins form a
SNARE complex. Additionally using the intestinal STC-1
cell line that harbors many features of native intestinal chol-
ecystokinin (CCK)-producing cells [26,27], we show that treat-
ment of permeabilized cells with Tetx results in a marked
inhibition of Ca2-induced CCK exocytosis, thus emphasizing
a functional role for a tetanus toxin-sensitive SNARE in a
model of intestinal endocrine cells.
2. Materials and methods
2.1. Materials
Monoclonal antibody against rat syntaxin-1 (6D2) was prepared as
described [28]. Mouse monoclonal antibody against SNAP-25 (SMI
81) was from Sternberger Monoclonals Inc. (Baltimore, USA). Poly-
clonal antisera to SNAP-25 (residues 195^206, common to mouse, rat
and human) and to rat VAMP-2 (residues 2^20) were prepared as
previously described [7,13]. These antibodies cross-reacted with the
di¡erent species used in this study, including human material (6D2
and anti-VAMP-2: Y. Shimazaki and M. Takahashi, unpublished;
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anti-SNAP-25: S. Catsicas, unpublished). Polyclonal antisera to rat
VAMP-1 (MC9; residues 1^15) and to rat VAMP-3 (MC16; residues
1^14) were kindly provided by Dr. P. De Camilli (Yale University,
New Haven, USA). Horseradish peroxidase- and FITC-labeled sec-
ondary antibodies were obtained from Jackson Laboratories (West
Grove, USA) and from Amersham (Les Ulis, France), respectively.
Cell culture media, fetal calf serum (FCS) and additives were from
Life Technologies (Cergy Pontoise, France). Rat brain extracts and
bovine adrenal chroma⁄n cell lysates were generously supplied by Dr.
A. Osen-Sand (Glaxo Institute for Molecular Biology, Geneva, Swit-
zerland) and Dr. M.F. Bader (INSERM U338, Strasbourg, France),
respectively. Streptolysin-O (SL-O) was produced and puri¢ed as de-
scribed [29]. Tetx light chain was generously provided by Dr. U.
Weller (University of Mainz, Germany). Protein G-Sepharose, bovine
serum albumin (BSA), Triton X-100, sodium orthovanadate, aproti-
nin, leupeptin and phenylmethylsulfonyl £uoride (PMSF) were from
Sigma (Saint Quentin Fallavier, France). All other reagents were of
analytical grade.
2.2. Cell lines and culture conditions
The following cell lines were used in this study: STC-1 (mouse
small intestine endocrine cell line, [30]), GLUTag (mouse large bowel
endocrine cell line [31]), HIT-T15 (hamster beta cell line, ATCC CRL
1777), CA-77 (rat medullary thyroid carcinoma [32]), IEC-6 (rat in-
testinal epithelial crypt cell line, [33]), HT-29 and Caco-2 [human
colon adenocarcinoma cell lines (ATCC HTB 38 and HTB 37, respec-
tively)]. The following cell culture conditions were used: STC-1 cells
in RPMI with 5% FCS; HIT-T15 cells in RPMI with 10% FCS, 32.5
WM glutathione and 0.1 WM selenous acid; IEC-6 cells in DMEM
with 10% FCS and 0.1 IU/ml insulin; CA-77 in Ham-F-10/DMEM
(1:1) with 10% FCS; GLUTag, HT-29 and Caco-2 cells in DMEM
with 10% FCS. All culture media were supplemented with 2 mM
glutamine and antibiotics (100 IU/ml penicillin and 50 WM strepto-
mycin) and cells were grown in a humidi¢ed CO2/air (5:95%) incuba-
tor at 37‡C.
2.3. Immunoprecipitation
Cells were solubilized in immunoprecipitation bu¡er (50 mM
HEPES, 150 mM NaCl, 10 mM Na4P2O7, 10 mM EDTA, 2 mM
Na3VO4, 100 mM NaF, 1% Triton X-100, 100 units/ml aprotinin,
20 WM leupeptin, 0.2 mg/ml PMSF, pH 7.5) for 15 min on ice. Cell
extracts were clari¢ed by centrifugation for 15 min at 14 000Ug and
then incubated with monoclonal SNAP-25 antibody preadsorbed to
protein G-Sepharose. Beads were subsequently washed twice in im-
munoprecipitation bu¡er, resuspended in Laemmli bu¡er and boiled
before separation on 12% SDS-PAGE.
2.4. Immunoblots
After SDS-PAGE, proteins were transferred onto nitrocellulose
sheets (Portran Ba 85, Schleicher and Schuell, Ecquevilly, France).
Membranes were blocked using 5% non-fat dry milk in Tris-bu¡ered
saline containing 0.2% Nonidet P-40, and exposed to the antibodies
overnight at 4‡C in the same bu¡er. After incubation with appropriate
secondary antibodies conjugated to horseradish peroxidase, blots were
developed using the ECL method (Pierce, Rockford, USA). Protein
concentrations were determined by the Bradford method (Bio-Rad,
Ivry sur Seine, France).
2.5. Immunocytochemistry
STC-1 and GLUTag cells were grown for two days before immu-
no£uorescence staining. Cells were washed in PBS and ¢xed for 10
min in PBS, 4% paraformaldehyde. After washing twice in PBS, cells
were permeabilized in PBT (PBS containing 0.3% Triton X-100 and
0.5% BSA) and then incubated with anti-syntaxin-1 (6D2, 1/200),
anti-SNAP-25 (SMI 81, 1/1000) and anti-VAMP-2 (1/250) antibodies
for 1 h. Following incubation with FITC-conjugated anti-mouse or
anti-rabbit IgG antibody (1/100), immuno£uorescence was visualized
with a Leitz £uorescence microscope or with a Zeiss LSM10 laser
confocal microscope. No staining was observed in cells treated iden-
tically but without addition of primary antibodies.
2.6. Streptolysin-O permeabilization, neurotoxin treatment and
CCK determination
Permeabilization experiments were performed as described previ-
ously [18,34] with slight modi¢cations according to [35]. Brie£y,
STC-1 cells were washed once in a Ca2-free Krebs bu¡er and resus-
pended in ice-cold KG bu¡er (in mM: 140 K-glutamate, 5 NaCl,
7 MgSO4, 20 HEPES, 0.4 EGTA, pH 7.0) containing 1 IU/ml SL-O.
After 5 min, the cells were washed free of unbound SL-O by centrif-
ugation and resuspension in KG bu¡er at 4‡C. STC-1 cells (2.5 105
cells/60 Wl ¢nal volume) were then incubated at 37‡C for 10 min in
KG bu¡er supplemented with 2.5 mM Na2ATP in the presence of the
indicated amount of light chain Tetx [21,36,37]. The e⁄ciency of per-
meabilization (more than 95% of cells permeabilized) was checked
with 0.04% Trypan blue. Cells were stimulated by addition of 60 Wl
KG bu¡er containing 2.5 mM Na2ATP, EGTA (10.2 mM, ¢nal con-
centration) and CaCl2 to regulate the level of free Ca2 [18] and
incubated for 7 min at 37‡C. The reaction was then quenched by
the addition of 200 Wl ice-cold KG bu¡er and cells were sedimented.
The amount of CCK released into the supernatant and the remaining
immunoreactive material in the pellets were determined by RIA with
antiserum 39A as previously described [38]. The detection limit and
ID50 of the assay were 0.5 and 4.0 pM, respectively. Results were
expressed as a percentage of total cell content [(peptide released in
mediumU100)/(peptide released in medium+cell content at the end of
the incubation)].
2.7. Statistical analysis
Results were analyzed by one-way analysis of variance (ANOVA)
followed by post hoc comparison of Fisher. Di¡erences between two
means with a P value 6 0.05 were regarded as signi¢cant. All values
were expressed as means þ S.E.M. of at least three experiments.
3. Results and discussion
3.1. Expression of syntaxin-1, SNAP-25 and VAMP-2 in
intestinal endocrine cell lines
The presence of syntaxin-1, SNAP-25 and VAMP-2 was
investigated by immunoblotting in the enteroendocrine cell
lines STC-1 and GLUTag, and for comparison in the intesti-
nal non-endocrine cell lines IEC-6, HT-29 and Caco-2, and in
the non-intestinal endocrine cell lines HIT-T15 and CA-77
(Fig. 1A). Syntaxin-1, SNAP-25 and VAMP-2 were expressed
in the intestinal CCK-producing cell lines STC-1 and GLU-
Tag, as well as in CA-77 medullary thyroid carcinoma cells
that transcribe the CCK gene [27]. The three SNAREs were
also detected in the beta cell line HIT-T15 (this report and
[17,19,20,24]). Surprisingly, a slight expression of VAMP-2
appeared in the non-transformed intestinal epithelial cell line
IEC-6, and in the colon adenocarcinoma cell line HT-29 but
not Caco-2. In contrast, SNAP-25 and syntaxin-1 expression
was not detected in IEC-6, HT-29 and Caco-2 cells. As ex-
pected [5^8,12], the expression of these proteins was detected
at a high level in bovine adrenal chroma⁄n cells and in rat
brain extracts (Fig. 1A).
The 6D2 anti-syntaxin-1 antibody used in this study recog-
nizes both syntaxin-1A and -1B isoforms. These two isoforms
were present in the brain (Fig. 1B and [1,6]), as well as in
neuroendocrine chroma⁄n cells (Fig. 1B). In contrast, the
syntaxin-1A isoform, which shows a faster electrophoretic
mobility [1], was found to be the most abundant isoform in
the endocrine cell lines STC-1, GLUTag, CA-77 and HIT-
T15. A similar pattern of syntaxin-1 expression has been de-
scribed in pancreatic and anterior pituitary endocrine cells
[14^16].
Subcellular localization of syntaxin-1, SNAP-25 and
VAMP-2 in the enteroendocrine cell lines STC-1 (Fig. 2)
and GLUTag (data not shown) was examined by immunocy-
tochemistry and confocal laser microscopy analysis. Essen-
tially all STC-1 and GLUTag cells were stained with the
anti-SNARE protein antibodies. Syntaxin-1 (Fig. 2A) and
SNAP-25 (Fig. 2B) staining was localized to the periphery
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of the cells, while very little cytoplasmic labeling was ob-
served. In contrast, confocal laser microscopy showed a
patchy intracellular distribution for VAMP-2 (Fig. 2C). Over-
all, these results suggest that syntaxin-1 and SNAP-25 could
act as plasma membrane t-SNAREs in the enteroendocrine
cells STC-1 and GLUTag, while the cytoplasmic distribution
of VAMP-2 suggests a v-SNARE status for this protein.
3.2. Complex formation of syntaxin-1, SNAP-25 and VAMP-2
in intestinal endocrine cell lines
During neurotransmitter exocytosis, the targeting of synap-
tic vesicles to plasma membrane has been proposed to occur
through the formation of a stable ternary complex composed
of VAMP/synaptobrevin (v-SNARE), syntaxin-1 and SNAP-
25 (t-SNAREs) [1,9]. This complex could be isolated from
detergent extracts by immunoprecipitation with syntaxin-1
or SNAP-25 antibodies [1]. The formation of this synaptic
core complex was also described in adrenal chroma⁄n cells
[12], PC12 pheochromocytoma cells [13] and RINm5F insuli-
noma cells [13]. To further examine the role of the SNARE
proteins present in enteroendocrine cell lines, we investigated
the formation of stable ternary complexes containing syntax-
in-1, SNAP-25 and VAMP-2 by immunoprecipitation with the
SNAP-25 antibody SMI 81 (Fig. 3). Immunoblotting of syn-
taxin-1, SNAP-25 and VAMP-2 demonstrated that proteins
that are part of the SNARE complex in brain (Fig. 3 and
[1,9]) could also be detected in the immunoprecipitate from
STC-1, GLUTag, HIT-T15 and CA-77 cells (Fig. 3). No non-
speci¢c binding was observed when immunoprecipitation was
performed without SNAP-25 antibody (not shown) or with
detergent-extracts from Caco-2 cells (Fig. 3), that do not ex-
press any of the three SNARE proteins investigated here (Fig.
1). Similar results were obtained when using the anti-SNAP-
25 polyclonal antiserum for immunoprecipitation (not
shown).
3.3. Tetanus toxin cleaves VAMP-2 and VAMP-3, and inhibits
Ca2+-induced CCK release in streptolysin-O-permeabilized
STC-1 cells
Tetanus toxin is a zinc-dependent protease that cleaves
VAMP-2 [22,23,25] and VAMP-3/cellubrevin [39] in a highly
selective manner. The toxin was shown to inhibit synaptic
vesicle exocytosis [22,23] as well as catecholamine [21] and
insulin [17,19,20] release from adrenal chroma⁄n and insuli-
noma cells, respectively. Here, we permeabilized STC-1 cells
with streptolysin-O to allow Tetx to enter cells. The e¡ects of
the Tetx treatment were analyzed on both VAMPs cleavage,
and Ca2-induced CCK secretion (Fig. 4). Tetx treatment of
SL-O-permeabilized cells was found to cause the cleavage of
VAMP-2 in a dose-dependent manner, but not of syntaxin-1,
SNAP-25 or VAMP-1, the latter being expressed in STC-1
cells (Fig. 4, upper panel). The CCK secretion evoked by a
high Ca2 concentration (4.2 þ 0.6% vs. 2.1 þ 0.2% of total cell
content for 40 WM vs. 0.1 WM free Ca2, respectively) was
inhibited when cells were treated with Tetx (Fig. 4, lower
panel). These observations argue for the involvement of teta-
nus toxin-sensitive protein(s) in CCK exocytosis from enter-
oendocrine cells. This protein could be the SNARE protein
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Fig. 2. Immuno£uorescence location of SNARE proteins in the in-
testinal endocrine STC-1 cells. Immunocytochemistry was done as
described in Section 2 with (A) anti-syntaxin-1 (1/200), (B) anti-
SNAP-25 (1/1000) and (C) anti-VAMP-2 (1/250) antibodies. Primary
antibodies were detected with FITC-coupled secondary antibodies
and visualized by indirect £uorescence microscopy (A^B), or by la-
ser confocal, in phase contrast (C, left panel) and £uorescence (C,
right panel), microscopy. Scale bars = 10 Wm.
Fig. 1. Immunoblot analysis of SNAREs proteins in cells and tissue
of di¡erent origin. Indicated amounts of solubilized extracts were
subjected to SDS-PAGE and transferred to nitrocellulose blot. A:
SNARE proteins were visualized with monoclonal anti-syntaxin-1
(6D2), monoclonal anti-SNAP-25 (SMI 81) and polyclonal anti-
VAMP-2 antibodies. B: Extracts were loaded onto a 6 M-urea
SDS-polyacrylamide gel [1]. After electrophoresis, proteins were
transblotted onto nitrocellulose and immunostained with anti-syn-
taxin-1 (6D2) antibody. Results are representative of three inde-
pendent experiments.
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VAMP-2 identi¢ed in STC-1 and GLUTag CCK-producing
cells, and involved in insulin secretion from pancreatic beta
cells [20]. However, a functional role of the ubiquitously ex-
pressed tetanus toxin-substrate VAMP-3/cellubrevin [39], also
present in STC-1 cells (Fig. 4, upper panel), cannot be ex-
cluded. Indeed, this protein, that was shown to participate
with VAMP-2 in insulin exocytosis from HIT-T15 cells [20],
was cleaved by Tetx treatment of STC-1 cells (Fig. 4, upper
panel). In addition, the inhibition of CCK secretion correlated
with the cleavage of VAMP-2 and of VAMP-3, the half-max-
imum and maximum concentrations of Tetx being about 12
and 50 nM for both VAMPs cleavage and inhibition of CCK
release. These concentrations were comparable to those re-
quired for VAMP-2 and VAMP-3 cleavage and insulin exo-
cytosis inhibition in insulin-secreting cells [17]. Whether
VAMP-2 or VAMP-3, or both VAMPs, are required in the
exocytotic process of CCK remains to be elucidated.
In conclusion, this study indicates that the three synaptic
core complex proteins, syntaxin-1, SNAP-25, and VAMP-2,
are expressed in enteroendocrine CCK-secreting cell lines. In
addition, a Tetx-sensitive protein (for example, VAMP-2 and/
or VAMP-3) is required for Ca2-induced CCK exocytosis in
the STC-1 cell line. A next challenge will be to understand
how physiological stimuli, such as nutrients, hormones and
neurotransmitters, are able to modulate the exocytotic machi-
nery of intestinal CCK-producing cells, and how this organ-
ization could be disrupted in states of neuroendocrine secret-
ing tumors.
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